首页 | 本学科首页   官方微博 | 高级检索  
     

当归对自发性高血压大鼠心肌miR-122的影响及其生物信息学分析
引用本文:陈蓓蓓,马睿玲,孙少伯,纪禄风,石向慧,伊琳. 当归对自发性高血压大鼠心肌miR-122的影响及其生物信息学分析[J]. 中国动脉硬化杂志, 2016, 24(4): 345-349
作者姓名:陈蓓蓓  马睿玲  孙少伯  纪禄风  石向慧  伊琳
作者单位:中西医结合学院,;中西医结合学院,;基础医学院, 甘肃省兰州市 730000;中西医结合学院,;中西医结合学院,;中西医结合学院,
基金项目:国家自然科学基金项目(81460669);甘肃省第十批科技计划项目(1310RJZA084)
摘    要:目的分析当归对自发性高血压大鼠心肌miR-122的影响及其生物信息学分析。方法将自发性高血压大鼠分为当归组、模型组、卡托普利组、当归+卡托普利组,同周龄的Wistar大鼠作为正常对照组,测定用药前后不同组别鼠尾动脉收缩压。分组给药4周后,取大鼠心肌组织进行miRNA表达谱的测定。结果当归可降低自发性高血压大鼠的血压水平。当归组表达上调的miRNA有13个,表达下调的miRNA有16个;卡托普利组表达上调的miRNA有15个,表达下调的miRNA有13个;当归+卡托普利组表达上调的miRNA有4个,表达下调的miRNA有21个。对在三组中都表达上调的miR-122进行生物学过程富集分析,发现与氨基酸转运相关的基因Slc7a1。通过对差异表达的miRNA进行靶基因预测,当归组有8个miRNA含有靶基因Slc7a1,卡托普利组有11个miRNA含有靶基因Slc7a1,当归+卡托普利组有6个miRNA含有靶基因Slc7a1。结论当归对自发性高血压大鼠miR-122表达产生影响,可能通过其靶基因Slc7a1影响内皮功能,进而调节血压,为进一步的研究提供了依据。

关 键 词:当归    自发性高血压大鼠    微小RNA
收稿时间:2015-11-23
修稿时间:2016-01-14

Effect of Angelica on miR-122 in Myocardial Tissue of Spontaneously Hypertensive Rats and Its Bioinformatics Analysis
CHEN Bei-Bei,MA Rui-Ling,SUN Shao-Bo,JI Lu-Feng,SHI Xiang-Hui and YI Lin. Effect of Angelica on miR-122 in Myocardial Tissue of Spontaneously Hypertensive Rats and Its Bioinformatics Analysis[J]. Chinese Journal of Arteriosclerosis, 2016, 24(4): 345-349
Authors:CHEN Bei-Bei  MA Rui-Ling  SUN Shao-Bo  JI Lu-Feng  SHI Xiang-Hui  YI Lin
Affiliation:College of Integrated Traditional and Western Medicine,;College of Integrated Traditional and Western Medicine,;College of Basic Medicine, Gansu University of Chinese Medicine, Lanzhou, Gansu 730000, China;College of Integrated Traditional and Western Medicine,;College of Integrated Traditional and Western Medicine,;College of Integrated Traditional and Western Medicine,
Abstract:Aim To study the effect of angelica on miR-122 in myocardial tissue of spontaneously hypertensive rats (SHR) and its bioinformatics analysis. Methods All the spontaneously hypertensive rats were divided into angelica group, model group, captopril group and angelica captopril group, the same-age Wistar rats as normal control group, then the systolic blood pressure of the tails of all rats in different groups were measured before and after treatments. After 4 weeks, myocardial tissue of the rats were extracted to test miRNA expression profiling. Results Angelica can reduce blood pressure levels in SHR. 13 miRNAs were found up-regulated and 16 miRNAs down-regulated in angelica group, and 15 miRNAs were found up-regulated and 13 miRNAs down-regulated in captopril group and 4 miRNAs were found up-regulated and 21 miRNAs down-regulated in angelica captopril group. We made a analysis of biological process of miR-122, which was up-regulated in all of the three groups, and an amino acid transport gene Slc7a1 was found. By miRNA target precdiction, 8 miRNAs were found targeted by Slc7a1 in angelica group and 11 miRNAs were found targeted by Slc7a1 in captopril group and 11 miRNAs were found targeted by Slc7a1 in captopril group. Conclusions Angelica can regulate the expression of miR-122, with the mechanism that angelica influenced endothelial function by the target gene Slc7a1 of miR-122 and resulted in regulation of blood pressure, which established a foundation of further research.
Keywords:Angelica   Spontaneously Hypertensive Rat   MicroRNA
本文献已被 CNKI 等数据库收录!
点击此处可从《中国动脉硬化杂志》浏览原始摘要信息
点击此处可从《中国动脉硬化杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号